Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients

…, M Vlaming, AS Merseburger, MC Roesch… - British Journal of …, 2022 - nature.com
Background Non-invasive urine-based biomarkers can potentially improve current diagnostic
and monitoring protocols for bladder cancer (BC). Here we assess the performance of …

Targeting cyclin-dependent kinase 7—association between CDK7 and pMED1 expression in prostate cancer tissue

…, V Joerg, E Dreyer, MC Roesch, C Seidel… - …, 2022 - academic.oup.com
Marie C Roesch , Marie C Roesch … (c) Nuclear CDK7 and pMED1 expression show significant
correlation in human PCa tissues. (d) Mean CDK7/pMED1-score in different PCa tissues. …

[HTML][HTML] Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal …

…, I Heidegger, M Mokou, A Latosinska, MC Roesch… - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer is the most frequent cancer type and one of the leading
causes of death in men globally. Multiple biomarkers analyzed in urine have been proposed …

[HTML][HTML] EpCAM tumor specificity and proteoform patterns in urothelial cancer

FF Dressler, S Hinrichs, MC Roesch… - Journal of Cancer …, 2023 - Springer
Background The role of the epithelial cell adhesion molecule (EpCAM) in cancer is still
unclear. EpCAM cleavage through regulated intramembrane proteolysis results in fragments …

[HTML][HTML] Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment

…, MM Heck, C Henkenberens, MC Roesch, C Käding… - PLoS …, 2022 - journals.plos.org
Introduction Since the beginning of the pandemic in 2020, COVID-19 has changed the medical
landscape. International recommendations for localized prostate cancer (PCa) include …

[HTML][HTML] Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer

M Frantzi, I Heidegger, MC Roesch… - World Journal of …, 2022 - Springer
Purpose Prostate cancer (PCa) is one of the most common cancers and one of the leading
causes of death worldwide. Thus, one major issue in PCa research is to accurately …

[HTML][HTML] The gene expression landscape of prostate cancer BM reveals close interaction with the bone microenvironment

…, K Duan, C Watermann, K Hempel, MC Roesch… - International Journal of …, 2022 - mdpi.com
Bone metastatic (BM) prostate cancer (PCa) belongs to the most lethal form of PCa, and
therapeutic options are limited. Molecular profiling of metastases contributes to the …

[HTML][HTML] The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control study

T Ozimek, JR Wiessmeyer, JP Struck, MC Roesch… - BMC urology, 2022 - Springer
Background The insertion of a ureteral access sheath (UAS) is a frequent procedure during
flexible ureteroscopy (fURS) to facilitate kidney stone treatment. The aim of this study was to …

[HTML][HTML] Inhibition of cyclin-dependent kinase 8/cyclin-dependent kinase 19 suppresses its pro-oncogenic effects in prostate cancer

A Offermann, V Joerg, F Becker, MC Roesch… - The American Journal of …, 2022 - Elsevier
Progression of prostate cancer (PCa) is characterized by metastasis and castration resistance
after response to androgen deprivation. Therapeutic options are limited, causing high …

Up-regulation of POM121 is linked to prostate cancer aggressiveness and serves as a prognostic biomarker

F Becker, A Offermann, MC Roesch, V Joerg… - … Oncology: Seminars and …, 2022 - Elsevier
Purpose Nucleoporins as components of the nuclear pore complex (NCP) are known for
regulating nuclear-cytoplasmatic transport. Recently, the nucleoporin POM121 was found to …